Sheets Smith Wealth Management Purchases 550 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Sheets Smith Wealth Management raised its position in Option Care Health, Inc. (NASDAQ:OPCH) by 2.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,856 shares of the company’s stock after buying an additional 550 shares during the period. Sheets Smith Wealth Management’s holdings in Option Care Health were worth $553,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. Envestnet Asset Management Inc. increased its position in shares of Option Care Health by 2.8% during the second quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company’s stock valued at $6,407,000 after acquiring an additional 6,283 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Option Care Health by 6.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after purchasing an additional 218,844 shares during the period. Intech Investment Management LLC purchased a new stake in shares of Option Care Health during the 2nd quarter valued at $1,014,000. Bank of Montreal Can raised its stake in shares of Option Care Health by 2.9% during the 2nd quarter. Bank of Montreal Can now owns 51,667 shares of the company’s stock worth $1,461,000 after purchasing an additional 1,477 shares during the period. Finally, Squarepoint Ops LLC purchased a new position in shares of Option Care Health in the 2nd quarter worth about $4,979,000. Institutional investors own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on OPCH. Barrington Research raised their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. Truist Financial decreased their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and dropped their price target for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.86.

Option Care Health Trading Down 0.5 %

Shares of OPCH stock opened at $29.31 on Thursday. The stock has a market capitalization of $4.99 billion, a price-to-earnings ratio of 24.63, a PEG ratio of 2.09 and a beta of 1.31. The company’s fifty day simple moving average is $23.96 and its two-hundred day simple moving average is $27.77. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.63. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.